Arca Biopharma sell StockNews.com
Start price
09.09.23
/
50%
€1.88
Target price
09.09.24
-
Performance (%)
166.36%
End price
10.09.24
-
Summary
This prediction is currently being closed. The SELL prediction by StockNews_com for Arca Biopharma is trending in the completely wrong direction and now has a performance of 166.36%. StockNews_com has a follow-up prediction for Arca Biopharma where he still thinks Arca Biopharma is a Sell. A total of €2.85 was paid as dividends for this prediction. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arca Biopharma | - | - | - |
| iShares Core DAX® | -1.471% | 1.895% | 25.178% |
| iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
| iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
| iShares S&P 500 | 0.394% | 3.118% | 29.456% |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ABIO provided by MarketBeat
In the thread Trading Arca Biopharma
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten